New cholesterol pill trial aims to protect hearts in diabetes

NCT ID NCT07219602

Recruiting now Disease control Sponsor: NewAmsterdam Pharma Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a new drug, obicetrapib, alone or combined with ezetimibe, can lower 'bad' cholesterol (LDL-C) more effectively in people with type 2 diabetes or metabolic syndrome who are already on standard cholesterol medication. It's a Phase 3 trial involving 300 participants, comparing the new treatments against a placebo (inactive pill) over 84 days. The main goal is to see if the new drug options safely provide better cholesterol control.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Burke Internal Medicine
RECRUITING

Burke, Virginia, 22015-2234, United States
Burke International Medicine DBA Manassas Clinical Research Center
RECRUITING

Manassas, Virginia, 20110, United States
Central New York Clinical Research
RECRUITING

Manlius, New York, 13104, United States
Centricity Research dba Lucas Research
RECRUITING

Morehead City, North Carolina, 28557, United States
Clinical Research Institute of Arizona
RECRUITING

Sun City West, Arizona, 85375, United States
Clinical Trials of Texas dba Flourish Research
RECRUITING

San Antonio, Texas, 78229, United States
East Coast Institute of Research LLC
RECRUITING

Jacksonville, Florida, 32216, United States
East Coast Institute of Research LLC
RECRUITING

Lake City, Florida, 32055, United States
Floridian Clinical Research
RECRUITING

Miami Lakes, Florida, 33016, United States
Floridian Clinical Research
RECRUITING

Greensboro, North Carolina, 27408, United States
Inspira Health - Internal Medicine Associates
RECRUITING

Bridgeton, New Jersey, 08302, United States
Jefferson City Medical Group
RECRUITING

Jefferson City, Missouri, 65109, United States
Juno Research LLC - Medical Center
RECRUITING

Houston, Texas, 77054, United States
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
RECRUITING

Louisville, Kentucky, 40213, United States
MD Medical Research
RECRUITING

Oxon Hill, Maryland, 20745, United States
Montana Medical Research
RECRUITING

Missoula, Montana, 59808, United States
Scripps Health - Whittier Diabetes Institute
RECRUITING

La Jolla, California, 92037, United States
Summit Research Group
RECRUITING

Munroe Falls, Ohio, 44262, United States
UF Health Jackson
RECRUITING

Jacksonville, Florida, 32209, United States
Velocity Clinical Research
RECRUITING

Durham, North Carolina, 27710, United States

Conditions

Explore the condition pages connected to this study.

LIPIDEMIA METABOLIC SYNDROME (METS) TYPE 2 DIABETES (T2DM)